Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Author(s): Alexander Kenneth S, Kothapalli Madhu R, Dollimor David
Issue: Jan/Feb 1997 - Hospice Care
View All Articles in Issue
Note: Electronic version includes errata or revisions.
Abstract: The stability of a 40-µg/mL extemporaneously formulated syrup from commercially available levothyroxine sodium tablets, using sorbitol 70% as the diluting vehicle, was studied. The concentration of levothyroxine sodium in the formulation was 40 µg/mL. The protocol included accelerated stability testing at temperatures of 40°, 50°, 60° and 70°C and a high-performance liquid chromatography assay procedure using testosterone propionate as the internal standard. The data were analyzed using an Arrhenius plot to determine the shelf-life of the formulation. The shelf-life was found to be approximately 15 days at 25°C and 47 days at 5°C.
Related Keywords: Synthroid
Related Categories: GERIATRICS, PEDIATRICS, PEER-REVIEWED
Download in electronic PDF format for $35
|Related Articles from IJPC|
|Title (Click for Abstract / Details)||Author||Issue||Page||View/Buy|
|Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets||Alexander Kenneth S, Kothapalli Madhu R, Dollimor David||Jan/Feb 1997||60-63||Buy|
|Stability of Levothyroxine Sodium Injection in Polypropylene Syringes||Gupta Vishnu D||Nov/Dec 2000||482-483||Buy|